Advancing Cancer Research
The BIDMC Division of Hematology/Oncology is engaged in leading-edge basic, translational, and clinical cancer research. We participate in six of the National Cancer Institute-sponsored Specialized Programs in Research Excellence (SPORE) Grants at the Dana-Farber/Harvard Cancer Center. This includes lung, prostate, breast, ovarian, skin, and kidney research programs. Our investigators receive significant funding from the National Institutes of Health, and many are members of BIDMC's Cancer Research Institute.